APA (7th ed.) Citation

L, M., ER, L., PP, B., DO, W., SS, D., DA, R., . . . DS, H. (2019). Risk-based treatment for patients with first relapse or progression of rhabdomyosarcoma: A report from the Children's Oncology Group. Cancer, 125(15), 2602. https://doi.org/10.1002/cncr.32122

Chicago Style (17th ed.) Citation

L, Mascarenhas, et al. "Risk-based Treatment for Patients with First Relapse or Progression of Rhabdomyosarcoma: A Report from the Children's Oncology Group." Cancer 125, no. 15 (2019): 2602. https://doi.org/10.1002/cncr.32122.

MLA (9th ed.) Citation

L, Mascarenhas, et al. "Risk-based Treatment for Patients with First Relapse or Progression of Rhabdomyosarcoma: A Report from the Children's Oncology Group." Cancer, vol. 125, no. 15, 2019, p. 2602, https://doi.org/10.1002/cncr.32122.